Drug Shortage Report for APO-QUETIAPINE XR

Last updated on 2024-02-16 History
Report ID 216693
Drug Identification Number 02457253
Brand name APO-QUETIAPINE XR
Common or Proper name QUETIAPINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) QUETIAPINE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60 BTL
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-04-22
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2024-02-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-02-16 French Compare
v7 2024-02-16 English Compare
v6 2024-02-09 French Compare
v5 2024-02-09 English Compare
v4 2024-02-06 French Compare
v3 2024-02-06 English Compare
v2 2024-01-19 French Compare
v1 2024-01-19 English Compare

Showing 1 to 8 of 8